CLEAN Clean Science and Technology Q2 FY26 results (Jul–Sep 2025) and concall
Clean Science reported a challenging Q2 FY26 with standalone revenue and profit declines attributed to lower sales in established products, competitive intensity from Chinese suppliers, and demand uncertainty. Despite this, EBITDA margins remained resilient. The HALS segment showed strong sequential growth and margin improvement. The company is progressing with new product commercialization, with Performance Chemical 1 expected to launch soon, but management remained cautious on the overall market outlook and declined to provide specific full-year EBITDA guidance.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 2.9%, net profit down 6.8% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 238 | 241 | 264 | 243 | 245 +3% |
| EBITDA | 90 | 98 | 105 | 100 | 87 −3% |
| Net profit | 59 | 66 | 74 | 70 | 55 −7% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
